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ABSTRACT The 19-kDa protein encoded within the aden-
ovirus E1B gene is essential for transformation by adenovirus and
for proper regulation of viral early gene transcription. In order to
investigate the biological function of the 19-kDa ElB protein,
vectors were constructed to produce the 19-kDa protein in mam-
malian cells under the direction of heterologous promoters.
Surprisingly, during transient expression, the E1B 19-kDa pro-
tein specifically associated with and disrupted the organization of
intermediate riaments and the nuclear lamina, without disturb-
ing the organization of other cytoskeletal networks. These results
directly demonstrate an effect of a viral transforming protein on
the cytoskeleton and suggest a role for intermediate filaments and
the nuclear lamina in modulation of viral gene expression and the
process of oncogenic transformation.
The region of the adenovirus genome responsible for regu-
lating gene expression in productively infected cells and for
oncogenic transformation of primary cells is El. El is com-
posed of two distinct transcription units, designated ElA and
E1B. ElA encodes nuclear phosphoproteins with the capac-
ity to transactivate transcription of viral early promoters
(reviewed in ref. 1), stimulate cellular DNA synthesis (2, 3),
and immortalize primary cells (4, 5). The E1B gene is
required for proper regulation of viral gene expression in
productively infected cells (6-8) and for full manifestation of
the transformed phenotype (reviewed in refs. 9, 10). There
are two major proteins produced from the E1B transcription
unit, the 19-kDa and 55-kDa tumor antigens (Fig. 4), both of
which are involved in transformation (8, 11, 12). The E1B
55-kDa protein binds to the cellular tumor antigen p53 and
presumably contributes to the transformation process by this
association (13). But the E1B 19-kDa protein plays a major
role in transformation, since coexpression of ElA and the
E1B 19-kDa protein is sufficient for induction of foci in
primary baby rat kidney cells and growth of these cells in
long-term culture (49). Although Ha-ras, polyoma middle
tumor antigen (5), and pp6-src (14) can substitute for E1B in
transformation assays, the 19-kDa protein shows no homol-
ogy to known guanine nucleotide-binding proteins, protein
kinases, cell surface receptors, or growth factors. Therefore,
the involvement of the E1B 19-kDa protein in the transfor-
mation process likely occurs by a unique mechanism.
Mutational analysis of the E1B 19-kDa coding region re-
vealed that viral mutants were not defective for virus replica-
tion in productively infected cells (15-20). These mutants,
however, displayed pleiotropic phenotypes that made inter-
pretation of the primary role of the E1B 19-kDa protein
difficult (7). The phenotypes of E1B 19-kDa viral mutants
included the degradation of host cell and viral DNA (deg
phenotype), enhanced and unusual cytopathic effect (cyt
phenotype), the formation of large plaques (lp phenotype), and
a host range (hr) phenotype whereupon the mutant viruses
replicate more efficiently than the wild-type virus. Genetic
experiments demonstrated that (i) manifestation ofthe 19-kDa
mutant phenotypes was dependent upon expression of the
ElA proteins, suggesting an interaction between the ElA and
E1B 19-kDa proteins (20); (ii) the 19-kDa protein functioned to
protect DNA from degradation during infection; and (iii) it
acted as a negative regulator of ElA-dependent viral early
gene transcription (7). As the 19-kDa protein was found in the
cytoplasm and the nuclear envelope lamina (21, 22), the effect
of the 19-kDa protein on gene expression (7, 23-25) and DNA
integrity was likely to be indirect, possibly by way of an effect
on mRNA metabolism, chromatin and nuclear structure, or
the function of ElA proteins (7).
Since determination of E1B 19-kDa protein function was
refractory to standard genetic analysis, we decided to look
for a biological function of the 19-kDa protein by using
plasmid expression vectors to produce the 19-kDa protein in
cells, outside the realm of a productive infection. One dra-
matic effect of 19-kDa protein expression was the disruption
of intermediate filaments (IFs) and the nuclear lamina,
thereby suggesting the means by which a cytoplasmic onco-
protein functions in the transformation process and during
productive infection.
MATERIALS AND METHODS
Plasmid Constructions. Advenovirus sequences from the
left end of the viral genome (0-15.5 map units) encoding all
of early region 1 (El) (nucleotides 1-5778) were cloned into
pBR322. This plasmid, designated pEl, was composed of
wild-type viral DNA sequences from adenovirus 5 (nucleo-
tides 1-1336) and adenovirus 2 (nucleotides 1337-5778) (Fig.
4). A plasmid encoding the ElA region, pElA, was derived
from pEl by deletion of the E1B region between nucleotides
1769 (Sac I) and 3322 (Bgl II) (Fig. 4). A plasmid lacking ElA
coding sequences but with an intact E1B gene, pElB, was
derived from pEl by deletion of nucleotides 338 (Ssp I) to
1569 (Hpa I) (Fig. 4). Specific deletion ofE1B 19-kDa coding
sequences was accomplished by substituting a Hpa I to
HindIII fragment of pEl with viral DNA sequences from
Ad5dl337, which contains a deletion of nucleotides 1769-
1916 (18) (Fig. 4).
Expression of the E1B 19-kDa protein under the control of
the mouse metallothionein promoter (pMT19K) was con-
structed by cloning a 1.4-kilobase (kb) fragment containing
the promoter (E. Harlow, Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY) in front of E1B 19-kDa coding
sequences from nucleotides 1704-2256. Expression from the
overlapping E1B 55-kDa reading frame was prevented by a
point mutation at nucleotide 2022 (cytosine to thymine con-
version), which produces a stop codon in the second codon
Abbreviations: SV40, simian virus 40; IF, intermediate filament;
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of the 55-kDa reading frame without affecting the amino acid
sequence of the 19-kDa protein (8). Promoter and E1B
sequences were followed by simian virus 40 (SV40), small
tumor antigen intron and poly(A) sequences, nucleotides
4713-2536 from the SV40 genome, and cloned into pUC (Fig.
1). Expression of the E1B 19-kDa protein directed by the
cytomegalovirus promoter pCMV19K was accomplished by
substituting a 576-base-pair (bp) fragment containing the
CMV promoter and enhancer (ref. 26; C. Gorman, Genen-
tech, San Francisco, CA) for the metallothionein promoter in
pMT19K (Fig. 1).
Transfection Procedures. HeLa and COS cells were grown
in monolayer culture in Dulbecco's modified Eagle's medium
with 10% fetal bovine serum and were transfected at 50%
confluence. Transient expression assays were performed by
calcium phosphate coprecipitation (27) followed by a glycerol
shock at 4 hr after transfection.
Antibodies and Indirect Immunofluorescence. HeLa and
COS cells were grown on glass coverslips and fixed with
either methanol at -200C (22) or paraformaldehyde followed
by Triton X-100 extraction (28). The source of murine mono-
clonal antibodies was a follows: an anti-72-kDa heat shock
protein antibody (29) was kindly provided by W. Welch (Cold
Spring Harbor Laboratory, Cold Spring Harbor, NY); an
anti-lamin A and C (30) antibody was obtained from F.
McKeon (University of California, San Francisco, CA);
anti-rat cytokeratins 8 and 18 antibodies (31) were a generous
gift of B. Lane (Imperial Cancer Research Fund, England);
an anti-vimentin antibody was obtained from Boehringer
Mannheim; an anti-tubulin antibody (32) was provided by S.
Blose (Protein Data Bases, Huntington, NY); an anti-actin
antibody was purchased from Amersham. Rabbit polyclonal
antibodies directed against the E1B 19-kDa protein were
previously described (7, 16). Fluorescein isothiocyanate- and
rhodamine-conjugated rabbit anti-mouse and goat anti-rabbit
IgGs were affinity purified and purchased from Cappel. Cells
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FIG. 1. E1B plasmid expression vectors. The E1B 19-kDa coding
sequences were cloned either to direct expression from the metal-
lothionein (MT) (pMT19K) or the cytomegalovirus (CMV)
(pCMV19K) promoters. These plasmids also contained a stop codon
to prevent expression from the overlapping E1B 55-kDa reading
frame (see text).
were examined and photographed with a Zeiss Axiophot
microscope.
Extraction Procedures. Cytoskeletal preparations were iso-
lated from pCMV19K-transfected HeLa cells according to
Capco et al. (33) with minor modifications (34). Briefly, cells
plated on tissue culture dishes were extracted with 0.5% Triton
X-100; this was followed by extraction with 250 mM ammo-
nium sulfate and nuclease treatment (DNase I and RNase A).
The remaining insoluble proteins were analyzed by polyacryl-
amide gel electrophoresis and Western blotting (22).
RESULTS
Construction of E1B 19-kDa Plasmid Expression Vectors.
The E1B 19-kDa protein is a fairly abundant protein in
adenovirus-infected and transformed cells. To reproduce
these levels, the 19-kDa protein was expressed under the
control of strong, heterologous promoters, the mouse met-
allothionein and the CMV promoter enhancer (Fig. 1). These
plasmids, when introduced into human HeLa or simian COS
cells by calcium phosphate precipitation, transiently express
the E1B 19-kDa protein to levels comparable to those found
in infected and transformed cells. The transiently expressed
19-kDa protein localized to the cytoplasm and nuclear enve-
lope of transfected cells (see below), closely resembling its
intracellular locale in transformed cells and in infected cells
at intermediate times after infection (22).
Transient Expression of the E1B 19-kDa Protein Disrupts IFs
and the Nuclear Lamina. Transfection of either HeLa or COS
cells with the pCMV19K or pMT19K expression vector
resulted in a subtle alteration in cell morphology. We there-
fore tested the possibility that expression of the E1B 19-kDa
gene product could affect cell architecture. In normal HeLa
cells or HeLa cells transfected with carrier DNA, the IFs
existed as long filaments that extended from the vicinity of
the nuclear envelope to the cell periphery (Fig. 2). Drastic
alterations in the distribution ofvimentin-containing IFs were
observed in many of the cells that expressed the 19-kDa
protein. Routinely, 10-50% of cells transfected with the
pCMV19K plasmid expressed the 19-kDa and 12-50% of
those had severe perturbations in the IF system at 48 hr after
transfection. IF disruption was time dependent, occurring in
eventually all 19-kDa-expressing cells by 72-96 hr. The IFs
became detached from the nuclear envelope and the plasma
membrane, formed large clusters in the cytoplasm, and often
appeared fragmented (Fig. 2). The 19-kDa protein was often
observed to colocalize with the disrupted IFs in the cyto-
plasm (Fig. 2).
Vimentin shares extensive amino acid and secondary struc-
ture homologies with the nuclear lamin proteins (30, 35).
Furthermore, the 19-kDa protein copurifies with the lamina
and has been localized there by immunoelectron microscopy
(22). We therefore investigated the possibility that the 19-kDa
protein might also disturb nuclear lamina structure in addition
to cytoplasmic IFs. Lamin antibodies stain the nuclear enve-
lope lamina in a uniform fashion, but 7% of 19-kDa protein-
expressing cells at 48 hr after transfection possessed holes in
the lamina (Fig. 2). The degree of lamina disruption increased
with time and the level of 19-kDa expression and is underrep-
resented in Fig. 2 only because one focal plane is shown. As
in the case of vimentin staining, the 19-kDa staining of the
lamina was coincident with that of the lamins (Fig. 2).
Cytokeratins are another class of cytoplasmic IF-related
proteins (36). In 19-kDa-expressing cells some disruption of
the cytokeratin network was observed but it was not as
pronounced as that found for the vimentin-type IFs (data not
shown). Therefore, multiple classes of IFs are affected by
19-kDa expression, although vimentin and lamin networks
were predominantly affected.
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FIG. 2. Disruption of IFs and the lamina by 19-kDa expression in
transient assays. HeLa cells were transfected either with carrier
DNA or with pCMV19K plasmid DNA and at 48 hr after transfection
cells were fixed in either paraformaldehyde (upper panels) or meth-
anol (lower panels). Double-label indirect immunofluorescence was
performed with a rabbit polyclonal antibody directed against the ElB
19-kDa protein in conjunction with murine monoclonal antibodies
specific for vimentin (upper panels) or lamins (lower panels). The
phase-contrast and immunofluorescent staining for vimentin or
lamins and the ElB 19-kDa protein are shown for the same cells in
each horizontal row. (x550.)
ElB 19-kDa Expression Does Not Affect Tubulin and Actin
Networks. To establish whether the 19-kDa protein specifi-
cally altered IF-related structures or had a global effect on the
cytoskeleton, tubulin and actin distributions were examined
in cells transiently expressing the 19-kDa protein. In COS
cells 19-kDa expression resulted in massive fragmentation of
IFs (Fig. 3). Aggregation of vimentin staining was observed
in the perinuclear region coincident with 19-kDa staining. In
contrast to the disruption of IFs, microtubules (Fig. 3) and
microfilaments (data not shown) were completely unaffected.
The lack of severe alterations in cell morphology caused by
IF disruption is likely due to specificity of the 19-kDa protein
for the IF system and maintenance of the tubulin and actin
cytoskeletal frameworks.
Disruption of IFs and Lamin Organization Is Specific for
Cells Expressing the ElB 19-kDa Protein. The organization of
IFs and lamina was examined by indirect immunofluores-
cence in HeLa and COS cells transfected with a series of El
plasmids, encoding ElA and ElB proteins under control of
their own promoters (Fig. 4). Transfection of a plasmid
encoding all of early region 1 (pEl) caused IF and lamina
disruption comparable to that ofpCMV19K (data not shown).
In fact, the level of 19-kDa expression in pEl-transfected
cells was equivalent to pCMV19K-transfected cells, presum-
ably due to trans-activation of the ElB promoter by ElA. No
IF and lamina disruption was observed after transfection of
pd1337 (Fig. 4), which encoded El but in addition contained
a deletion with the 19-kDa gene (data not shown). IF and
lamina disruption did occur in pElB-transfected cells, where
ElB expression is directed by the ElB promoter (Fig. 4),
although reduced level of 19-kDa expression in pElB resulted
in less frequent and less severe effects on IFs and the lamina
(data not shown). High-level expression ofthe 19-kDa protein
was clearly not required for IF and lamina disruption, al-
though it hastened its occurrence. Furthermore, as 19-kDa
expression did not induce expression of the 72-kDa heat
shock protein (data not shown), IF and lamina disruption did
not merely represent a manifestation of the stress response
due to expression of a viral protein in mammalian cells.
Perturbation of IFs and the lamina was not a transfection
artifact, nor was it due to overexpression of proteins in
general. Rather, IF and lamina disruption was a specific
consequence of expression of the ElB 19-kDa protein.
Cofractionation of the 19-kDa Protein with IFs. Colocaliza-
tion ofthe majority ofthe 19-kDa protein in the cytoplasm with
vimentin filaments in transient expression assays suggested
that the 19-kDa protein may interact directly with IFs, as it
does with the nuclear lamina (22). pCMV19K-transfected
HeLa cells were extracted with non-ionic detergent, followed
by high salt and nuclease treatments according to Capco et al.
(33). This procedure preserves insoluble IFs and the lamina
cytoskeleton (Fig. 5), while extracting most of the cellular
proteins (data not shown). The 19-kDa protein cofractionated
with the insoluble cytoskeleton in a similar fashion to that of
vimentin and lamins A and C (Fig. 5). Furthermore, colocal-
ization of the 19-kDa protein and vimentin was preserved in
isolated cytoskeletons (data not shown).
DISCUSSION
The adenovirus E1B 19-kDa transforming protein functions to
specifically disrupt IFs and the nuclear lamina of transfected
cells. To our knowledge, there has been no previous demon-
stration ofa non-IF protein other than an antibody (38, 39) that
is capable of specifically altering the organization of IFs and
the lamina in vivo. We have since observed IF and lamina
disruption in adenovirus-infected (unpublished data) and
transformed cells (49), which indicates that reorganization of
IFs is a normal consequence of 19-kDa expression and that it
is biologically relevant to the adenovirus life cycle. We can
now begin to address (i) how the 19-kDa protein disrupts IFs
and the lamina and (ii) why disruption ofthese structures could
prevent the occurrence of the pleiotropic phenotypes in ElB
mutant infected cells and promote oncogenic transformation.
Mechanism of IF and Lamina Disruption by the 19-kDa
Protein. Cytoplasmic IF proteins and the nuclear lamin
proteins are members of the same multigene family, sharing
extensive amino acid and secondary structure homologies
(30, 35). They also share the ability to assemble into insoluble
filamentous networks in the cytoplasm and the nucleus,
respectively (40-42). It was unusual and unexpected that
expression of a viral transforming protein was capable of
specifically disrupting structures that are resistant to disso-
lution by extreme regimens of nondenaturing detergents and
high salt extractions. We favor a direct mechanism for
19-kDa-mediated IF and lamina disruption for the simple
reason that the 19-kDa protein was found to colocalize and
cofractionate with IFs and the lamina. This implies that there
is a physical interaction between IF-related proteins and the
ElB 19-kDa protein.
We have not detected any proteolytic cleavage or altered
phosphorylation states of either vimentin or lamins resulting
Proc. Natl. Acad. Sci. USA 86 (1989)
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FIG. 3. Effect of 19-kDa expression on the distribu-
tion of microtubules. COS cells were transfected with
pCMV19K plasmid DNA and fixed with methanol at 48
hr after transfection. Double-label indirect immunofluo-
rescence was carried out with antibodies directed against
vimentin and the E1B 19-kDa protein (upper panels) or
tubulin and the E1B 19-kDa protein (lower panels). Note
that the same set of cells is shown in each horizontal row.
(x550.)
from 19-kDa expression, two mechanisms by which IF struc-
ture is thought to be regulated (reviewed in refs. 36, 43, 44).
Thus, IF and lamina disruption by the 19-kDa protein must
occur by a unique mechanism. As the 19-kDa protein was
found associated with IFs and the lamina in a detergent- and
salt-resistant form, the 19-kDa protein may bind to IFs and
the lamina and cause their disassembly.
Implications for IF and Lamina Function. The function of
either IFs or the lamina has not been determined (reviewed
in refs. 45, 46). IF disruption by the 19-kDa protein does not
cause gross alterations in cell morphology in transient expres-
sion assays, suggesting that IFs are not a dominant factor
governing cell shape. However, expression of the 19-kDa
protein in infected cells is required to prevent the occurrence
of abnormal cytopathic effect (7, 12, 15, 18). This disruption
of IFs may be necessary to modify cell morphology and
thereby prevent occurrence of the cyt phenotype and pre-
mature death of the host cell. In adenovirus-transformed
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FIG. 4. Schematic representation of El transcripts, polypeptides, restriction sites, and plasmids. (Upper) Numbers represent nucleotides
1-5778 of the adenovirus genome; relevant restriction sites are marked, and the locations of transcripts and coding regions are indicated. Arrows
indicate differentially spliced mRNAs, with carets marking introns removed by alternative splicing. Boxes indicate protein coding regions: solid
boxes, protein products related to the ElA 13S gene product; striped boxes, the E1B 19-kDa polypeptide; stippled boxes, protein products related
to the E1B 55-kDa polypeptide. A more comprehensive description of E1B 55-kDa related polypeptides can be found in Lewis and Anderson
(37). aa, amino acids. (Lower) Schematic representation of El plasmids: solid lines, sequences of adenovirus DNA carried by the plasmids; open
spaces, regions encompassing deletions.
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FIG. 5. Identification of the E1B 19-kDa protein as a component
of the vimentin cytoskeleton. Total cellular protein (TOT) or cyto-
skeletal preparations (CSK) from pCMV19K-transfected HeLa cells
were subjected to polyacrylamide gel electrophoresis. Fifteen per-
cent gels were either stained with Coomassie blue (CB) or analyzed
by Western blotting for lamins A and C, vimentin, or the EBB 19-kDa
protein, as indicated. Molecular weight markers (Mk) are indicated
in kDa.
cells, detachment of IFs from the plasma membrane may
alter the organization of the cell surface and subsequently
affect cell-cell attachment and growth regulation. This might
then promote anchorage-independent growth and tumorige-
nicity. Alternatively, given that Ha-ras (5), pp60csrc (14), and
the E1B 19-kDa protein (49) can all cooperate with ElA in a
transformation assay, an involvement of the 19-kDa protein
at some point in a signal transduction pathway might be
expected. Perturbation of IFs by the 19-kDa protein could
alter the organization of the plasma membrane or cytoplasm
in such a way as to affect signal transduction from the cell
surface to the nucleus. Possessing cells in which the IFs are
disrupted renders this hypothesis testable.
The lamin proteins are thought to be ubiquitous components
of eukaryotic cells and are probably essential for maintenance
of nuclear chromatin structure (reviewed in refs. 44, 46) and
nuclear assembly following mitosis (39, 47). Lamina disruption
by the 19-kDa protein could cause alterations in nuclear
structure and subsequently alter gene expression or growth
regulation and thus promote transformation. During produc-
tive infection, expression of the E1B 19-kDa protein prevents
the occurrence of DNA degradation and accelerated early
gene expression (7). Perturbation of the organization of the
lamina caused by the 19-kDa protein may alter nuclear or
chromatin structure and thereby prevent DNA degradation
and elevated viral gene expression. Studies with adenovirus
EiB 19-kDa viral mutants have demonstrated that correct
localization of the 19-kDa protein to the nuclear envelope is
required to prevent the degradation of host cell DNA (22).
Given that the 19-kDa protein modifies lamina organization,
physical association ofthe 19-kDa protein with the lamina may
be required to alter the lamina and maintain the integrity of
cellular DNA during adenovirus infection.
The findings presented here address not only the function
of an adenovirus-transforming protein but also the function of
those cellular components with which it interacts. The ElA
proteins associate with a number of cellular proteins, one of
which is the product of the retinoblastoma tumor suppressor
gene (48). The E1B 55-kDa protein has also been observed to
associate with another tumor suppressor gene, cellular p53
(13). The E1B 19-kDa protein associates with the nuclear
lamina and IFs and functions to interfere with their organi-
zation. It is becoming apparent that association of viral
transforming proteins with cellular components and subvert-
ing their function may represent the mechanism by which
DNA tumor viruses promote oncogenic transformation.
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